The National Institutes of Health has awarded the Oklahoma Medical Research Foundation $480,000 for research on dopamine’s role in Alzheimer’s disease.
alzheimer's disease
Will new Alzheimer’s drug deliver more than profits?
A new Alzheimer’s drug. That has always been the dream.
